Description
Measures IgG antibodies against the spike protein of SARS-CoV-2 using chemiluminescent microparticle immunoassay (CMIA). Used to assess immune response after COVID-19 infection or vaccination, particularly in determining the level of immunity.
This lab test includes home sample collection via a provided kit or by a clinician, and you'll receive a comprehensive physical health report with your results.